Abbott Laboratories (FRA:ABL)

Abbott Laboratories Statistics

Total Valuation

FRA:ABL has a market cap or net worth of EUR 196.78 billion. The enterprise value is 202.28 billion.

Market Cap	196.78B
Enterprise Value	202.28B

Important Dates

The next estimated earnings date is Wednesday, October 15, 2025.

Earnings Date	Oct 15, 2025
Ex-Dividend Date	Jul 15, 2025

Share Statistics

Current Share Class	1.74B
Shares Outstanding	n/a
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.73B

Valuation Ratios

The trailing PE ratio is 16.59 and the forward PE ratio is 24.35.

PE Ratio	16.59
Forward PE	24.35
PS Ratio	5.36
PB Ratio	4.55
P/TBV Ratio	11.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.07, with an EV/FCF ratio of 35.06.

EV / Earnings	17.06
EV / Sales	5.50
EV / EBITDA	20.07
EV / EBIT	28.54
EV / FCF	35.06

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.27.

Current Ratio	1.82
Quick Ratio	1.14
Debt / Equity	0.27
Debt / EBITDA	1.14
Debt / FCF	1.99
Interest Coverage	15.68

Financial Efficiency

Return on equity (ROE) is 30.93% and return on invested capital (ROIC) is 8.75%.

Return on Equity (ROE)	30.93%
Return on Assets (ROA)	6.62%
Return on Invested Capital (ROIC)	8.75%
Return on Capital Employed (ROCE)	11.78%
Revenue Per Employee	321,994
Profits Per Employee	104,032
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.74

Taxes

Income Tax	-5.18B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.83% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+10.83%
50-Day Moving Average	112.56
200-Day Moving Average	115.33
Relative Strength Index (RSI)	52.86
Average Volume (20 Days)	119

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.83

Income Statement

In the last 12 months, FRA:ABL had revenue of EUR 36.71 billion and earned 11.86 billion in profits. Earnings per share was 6.79.

Revenue	36.71B
Gross Profit	20.67B
Operating Income	7.08B
Pretax Income	6.73B
Net Income	11.86B
EBITDA	9.75B
EBIT	7.08B
Earnings Per Share (EPS)	6.79

Balance Sheet

The company has 6.20 billion in cash and 11.47 billion in debt, giving a net cash position of -5.27 billion.

Cash & Cash Equivalents	6.20B
Total Debt	11.47B
Net Cash	-5.27B
Net Cash Per Share	n/a
Equity (Book Value)	43.28B
Book Value Per Share	24.74
Working Capital	9.39B

Cash Flow

In the last 12 months, operating cash flow was 7.70 billion and capital expenditures -1.93 billion, giving a free cash flow of 5.77 billion.

Operating Cash Flow	7.70B
Capital Expenditures	-1.93B
Free Cash Flow	5.77B
FCF Per Share	n/a

Margins

Gross margin is 56.32%, with operating and profit margins of 19.28% and 32.43%.

Gross Margin	56.32%
Operating Margin	19.28%
Pretax Margin	18.32%
Profit Margin	32.43%
EBITDA Margin	26.57%
EBIT Margin	19.28%
FCF Margin	15.72%

Dividends & Yields

This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 1.88%.

Dividend Per Share	2.10
Dividend Yield	1.88%
Dividend Growth (YoY)	5.08%
Years of Dividend Growth	6
Payout Ratio	28.42%
Buyback Yield	0.08%
Shareholder Yield	1.96%
Earnings Yield	6.03%
FCF Yield	2.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:ABL has an Altman Z-Score of 5.6 and a Piotroski F-Score of 6.

Altman Z-Score	5.6
Piotroski F-Score	6